[Therapeutic action of nicergoline in the treatment of cerebrovascular and peripheral disorders].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D001288:Attention / Q000187:drug effects; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004873:Ergolines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D010146:Pain / Q000139:chemically induced; D011928:Raynaud Disease / Q000188:drug therapy
D004873:Ergolines; D009539:Nicotinic Acids
Attività terapeutica della nicergolina nel trattamento delle vasculopatie cerebrali e periferiche